drugset / Trial / NCT02497638
LIpitor and biGuanide to Androgen Delay Trial
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is a randomized trial examining the administration of a combination of biguanide metformin and atorvastatin ("Lipitor") to men who are experiencing rising prostate-specific antigen (PSA) levels, despite having undergone radical therapy (surgery and/or radiation).
Timeline
- Start
- 2021-12
- Primary completion
- 2021-12
- Completion
- 2022-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 20 mg | — |
| Subject | Metformin | Small molecule | 850 mg | — |